
‘Momentum Meets Reality,' Says Barclays About Tesla Stock
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Those numbers left little room for optimism. Revenue fell by 11.8% year-over-year to $22.49 billion, missing the Street's $22.74 billion forecast. Operating income slid to $0.9 billion, a 42% drop from the year-ago quarter. The end result was adjusted EPS of $0.40, falling short of expectations by $0.03.
But beyond the headline misses, what truly spooked investors were the signals about what lies ahead. Tesla now faces a growing list of challenges that could further weigh on performance. With the U.S. EV tax credit set to expire at the end of Q3, even Musk acknowledged that the company might endure a few 'rough quarters.' That outlook is further clouded by the impact of tariffs and legislative changes –particularly Trump's One Big Beautiful Bill, which eliminated penalties tied to NHTSA CAFE emissions standards. This change is expected to drag on high-margin regulatory credit sales.
For Barclays analyst Dan Levy, what's become 'abundantly clear' for Tesla over the past couple of years – particularly in the last year – is the 'widening gulf between narrative and fundamentals, with the stock increasingly disconnected from fundamentals.' This quarter 'further reinforced that gulf.'
Still, Musk isn't shying away from promoting the bigger vision. He reiterated that Tesla's future reaches far beyond cars, spotlighting AI and robotics as the company's next frontier. From Robotaxis and Optimus to a newly envisioned 'master plan' for a post-autonomy world, the CEO painted a picture of a company leading the charge in real-world AI. Musk even floated the idea of closer collaboration with xAI to bolster Tesla's technological edge.
'Alongside comments of expansion in Robotaxi,' says Levy, 'we believe the narrative remains intact.'
However, a compelling narrative can only do so much when fundamentals are shaky. As Levy pointed out, Tesla's core business remains choppy, and could worsen in the quarters ahead. Even the anticipated low-cost model, now likely arriving in Q4, may underwhelm if it's merely a simplified Model Y with limited appeal.
In the end, the earnings call seemed tailored to reassure long-term believers in Tesla's AI potential rather than to win over skeptics focused on near-term performance. The lack of new detail on Robotaxi progress didn't help, though bulls may pin their hopes on the upcoming AGM in November, which could reinforce the AI story.
'It is the long-term narrative which has kept the stock elevated,' Levy noted. 'Yet for the very near term, the air pocket in fundamentals may be a reminder that fundamentals don't matter… until they matter.'
Judging by the market's reaction, that moment may be arriving. For now, Levy assigns Tesla shares an Equal Weight (i.e., Neutral) rating, with a $275 price target, implying potential downside of 13% from current levels. (To watch Levy's track record, click here)
Looking beyond Levy, sentiment across Wall Street remains divided. TSLA stock holds a consensus rating of Hold, based on 14 Buys, 14 Holds, and 7 Sells. The average price target of $314.14 suggests shares will stay rangebound for the time being. (See TSLA stock forecast)
To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution
Henry Schein Inc. (NASDAQ:HSIC) stock is trading lower on Tuesday after the company reported its second-quarter earnings. The global healthcare solutions company reported adjusted earnings of $1.10 per share, down 10.6% year over year, missing the consensus of $1.20. Sales were $3.24 billion, beating the consensus of $3.22 billion. As reported, total net sales increased by 3.3%, reflecting 1.9% internal sales growth, 0.8% sales growth from acquisitions, and a 0.6% sales increase resulting from foreign currency Distribution and Value-Added Services sales for the quarter increased 2.9%, and by 2.4% in constant currencies compared with the second quarter of 2024. Total Global Distribution and Value-Added Services sales reached $2.73 billion, up from $2.65 billion a year ago. Henry Schein said Global Dental Distribution equipment sales for the quarter increased 3.0%, and by 1.6% in constant currencies. Sales growth was strong internationally and offset by lower sales in the U.S., resulting from a slowdown in orders beginning in May due to short-term economic uncertainty resulting from tariffs, which then returned to normal by the end of the quarter. Global Specialty Products sales for the quarter increased 4.2%, and by 3.3% to $386 million in constant currencies compared with the second quarter of 2024, reflecting continued growth in implant and biomaterial sales and endodontic consumables, offset partly by lower orthodontic sales. View more earnings on HSIC Global Technology sales for the quarter increased 7.4%, and by 6.6% in constant currencies to $167 million, reflecting strong sales growth in practice management systems, including Dentrix Ascend and Dentally cloud-based solutions, as well as in revenue cycle management products. 'Partnering with KKR Capstone, we have engaged two leading global management consulting firms to support our efforts to enhance distribution gross margins, including accelerating sales of our owned-products portfolio, and to support our ongoing company-wide initiatives to increase efficiencies. We expect these projects, which expand on our BOLD+1 strategy, to start producing results towards the beginning of 2026, and will support our ongoing initiatives to drive superior customer satisfaction and our financial goal of high-single digit to low-double digit earnings growth,' said Stanley Bergman, Chairman and CEO of Henry Schein. During the second quarter of 2025, the company recorded $23 million in restructuring costs and expects to achieve annual run-rate savings of over $100 million by the end of 2025. Outlook Henry Schein affirms fiscal 2025 adjusted earnings guidance of $4.80-$4.94 per share versus the consensus of $4.88. The company maintains 2025 sales guidance of $12.43 billion-$13.18 billion compared to the consensus of $12.96 billion. Adding a forward-looking perspective, investment firm William Blair said, 'Management also provided informal 2026 guidance for high-single- to low-double-digit EPS growth as the business stabilizes in 2025 and it starts to see some early benefits of its partnership with KKR and two other consulting firms. Consensus for 2026 currently calls for 8% EPS growth, so this is a welcome update, and we look for more concrete details on what these partnerships entail on the second-quarter call.' 'Overall, updates are mixed, and while we acknowledge management's execution on commercial/partner efforts, we expect second-half execution will be critical for durable valuation and share upside,' analyst Brandon Vazquez wrote in an investor note on Tuesday. Price Action: HSIC stock is trading lower by 8.80% to $64.37 at last check Tuesday. Read Next:Photo via Shutterstock Latest Ratings for HSIC Date Firm Action From To Feb 2022 Morgan Stanley Maintains Underweight Feb 2022 Credit Suisse Maintains Outperform Jan 2022 Morgan Stanley Initiates Coverage On Underweight View More Analyst Ratings for HSIC View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? HENRY SCHEIN (HSIC): Free Stock Analysis Report This article Henry Schein's 2025 Outlook Hinges On Strong Second-Half Execution originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
5 minutes ago
- Yahoo
Double Catalysts at Twin Hospitality: New CEO and Winning Sports Calendar to Drive Growth
Download the Complete Report Here By Rayk Riechmann A soft second quarter for our Twin Hospitality Group Inc. (Nasdaq: TWNP) is a short-term setback against a much more enticing view for the remainder of the year. TWNP shares have trended lower since last week's announcement of a 4.1% drop in revenue, largely due to legacy Smokey Bones locations that haven't yet been converted to Twin Peaks. However, we believe that the market's response creates a great entry point for two big reasons. One is the arrival of new CEO Kim Boerema, who took the helm at TWNP on May 15th and will lead the execution of the company's transformation. Mr. Boerema brings over three decades of restaurant industry experience across corporate and franchise business models to the table. With his proven ability to scale full-service brands and improve operational efficiency, the company has just what it needs and we are excited to see measurable results in the back half of the year. Second, a stronger sports calendar including the football season is a powerful catalyst for guest engagement and foot traffic which should boost top line results. TWNP has a clear strategy to leverage the fall sports calendar and increase check sizes through weekly watch parties, gear promotions, live DJs and more. When comparing LTM P/Sales ratios TWNP trades at a clear discount at 0.6x compared to peers at an average of 1.0x. As the company's profitability profile improves, we expect this gap to narrow. Click the link below to access our full earnings report. Download the Complete Report Here Contact: Rayk@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Axios
7 minutes ago
- Axios
Former X CEO Linda Yaccarino named CEO of GLP-1 telehealth company
Linda Yaccarino has a new job in a vastly different industry weeks after her exit as CEO of X, Elon Musk 's social discourse app. Why it matters: Musk hired the former NBCUniversal ad boss as the first permanent CEO of the platform formerly known as Twitter after he acquired it in 2022. She left X in July after a tumultuous tenure in which she repeatedly defended Musk while trying to convince displeased marketers to continue advertising on the platform. Driving the news: Yaccarino is the new CEO of eMed Population Health, a telehealth focused on GLP-1s, the blockbuster drugs used to treat diabetes and obesity. "There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before," Yaccarino said in a statement. Zoom in: Yaccarino comes on board as eMed is aiming to expand partnerships with employers and governments.